Objective: To analyse the association of alcohol consumption and blood lipids, haemostatic factors, and homocysteine in German adults by gender and age groups. Design: Cross-sectional population-based survey. Setting: Data from the German National Health Interview and Examination Survey 1998, representative for age, gender, community size, and federal state. Subjects: From a sample of 7124 Germans between 18 and 79 y old, 2420 women and 2365 men were selected. Only individuals who were not currently receiving medical treatment or did not have disorders related to cardiovascular disease were selected for this study. Results: Using analyses of variance, mean blood levels of total cholesterol, HDL cholesterol, HDL/total cholesterol ratio, total glycerides, fibrinogen, antithrombin III, and homocysteine adjusted for age, socioeconomic status, East/West Germany residence, body mass index, tobacco use, sports activity, and coffee consumption, if appropriate are presented by alcohol consumption groups (0, 40-10, 410-20, 420-30 and 430 g/day). The HDL/total cholesterol ratio increased with higher alcohol groups up to 10-20 g/day ( þ 15%) for women and 430 g/day ( þ 18%) for men, showing the strongest rise among men aged 55-79 y. Fibrinogen decreased with higher alcohol groups up to 10-20 g/day for women and 20-30 g/day for men. Among women, homocysteine levels showed a U-shaped curve with a minimum of 8.49 mmol/l at 10-20 g alcohol/day (À8%, reference: nondrinking), whereas an inverse association was observed for men. Conclusions: Moderate alcohol consumption is associated with favourable levels of several cardiovascular risk factors. The most favourable cardiovascular risk factor profile among women was observed among those drinking 10-20 g alcohol/day. Beneficial effects seem to be more pronounced among older men.
Introduction
Several studies have shown that alcohol consumption up to 20-30 g/day is associated with lower mortality from cardiovascular disease, especially from coronary heart disease (Keil et al, 1997; Thun et al, 1997) . This finding is mainly attributed to alcohol intervening in the atherogenetic process. Alcohol appears capable of inhibiting platelet function, enhancing fibrinolytic activity, altering vascular tone, and hindering proliferation and migration of arterial smooth muscle cells. A predominant mechanism seems to be the favourable effect of alcohol on lipid profile (Redmond et al, 2000; van Tol and Hendriks, 2001; Belleville, 2002) .
Recent results on the relation of alcohol consumption and homocysteine level are conflicting (Ubbink et al, 1998; Jacques et al, 2001) , although studies seem consistent in the effect of heavy alcohol drinking and increased homocysteine (Cravo et al, 1996; de la Vega et al, 2001) . Homocysteine is an independent risk factor of occlusive vascular disease (McCully, 1996; Graham et al, 1997) and should be considered in an overall risk assessment of alcohol consumption in relation to cardiovascular disease.
The purpose of this study was to compare differences in the levels of lipids in the blood, haemostatic factors, as well as homocysteine within different alcohol consumption groups in the general German population.
Subjects and methods

Data collection
The cross-sectional German National Health Interview and Examination Survey 1998 was conducted from October 1997 till March 1999 and included a total of 7124 women and men, 18-79 y old. The study population was selected by a stratified random sampling method based on population registries and was representative for age, gender, community size, and federal state. The overall participation rate was 61.4% (Bellach et al, 1998; Thefeld et al, 1999) .
Participants completed a comprehensive questionnaire answering questions about socioeconomic status, sports activity, tobacco use, and eating habits, including coffee and alcohol consumption, while under the supervision of trained personnel. In addition, a physician interviewed the participants about their medical history and drug use and performed an examination to determine, for instance, height and weight. Questionnaires were checked for proper completion and plausibility. Field work quality and standardisation were ascertained regularly.
For the purpose of the presented study, participants with a history of or prevailing heart disease (myocardial infarction, cardiac insufficiency, angina pectoris, and other circulatory disorders of the heart), hypertension, and diabetes were excluded from the analyses, as were persons taking heart disease medication, hypotensive drugs, antidiabetics, as well as lipid lowering drugs. Persons who reported venous thrombosis or circulatory disorders of the leg were additionally excluded from the analysis of fibrinogen level. Pregnancy was another exclusion criteria. Finally, a total of 2420 women and 2365 men (2365 women and 2321 men for analyses of fibrinogen) remained for analyses.
Venous blood samples were drawn for biochemical analyses after a fasting period of at least 3 h at a medical centre, using the Gel-Monovettensystem supplied by BectonDickinson (USA). EDTA-plasma for antithrombin III and fibrinogen analyses were stored 3 days at a temperature below À201C. Fibrinogen and antithrombin III in EDTAplasma were assayed using the immuno nephelometric method on a BNA-Analyzer (DADE-Behring Schwalbach, Germany). Erythrocytes were left 30-45 min at room temperature until fibrin production in Gel-Monovettes and were separated from serum by centrifugation at 3000 rpm for 10 min at 101C. The serum was frozen immediately and stored for analysis at À401C. Time between blood sampling and analysis never exceeded 7 days, except for homocysteine. Blood lipids were analysed on an automatic analyser type MEGA (Merck Darmstadt, Germany). Total serum cholesterol was assayed using the enzymatic CHOD-PAPmethod (Merck Darmstadt, Germany). HDL cholesterol was determined with an immunoseparation-based homogenous assay from WAKO (Japan). Triglycerides were measured with the GPO-PAP-method (Merck Darmstadt, Germany). Homocysteine was analysed with a commercially available HPLCKit (Immundiagnostik Bensheim, Germany) by using a Shimadzu chromatography system (Japan) with fluorescence detection within 1 year after storage at À401C. The CVs were 5.0% for fibrinogen, 5.2% for antithrombin III, 1.8% for total serum cholesterol, 1.2% for HDL cholesterol, 1.6% for triglycerides, and 5.4% for homocysteine. The blood serum was analysed under internal and external control at the laboratory of the Robert Koch-Institute.
Habitual alcohol consumption during the preceding year was assessed with a food frequency questionnaire which categorically asked for type, frequency, and dose of alcohol. Average alcohol consumption (in gram per day) was calculated by multiplying frequency and amount of alcohol from beer, wine, and spirits, respectively, using a standard ethanol content of 4.8 volume percent in beer, 11 volume percent in wine, and 33 volume percent in spirits to conversion, as proposed by Bühringer et al (2000) . If answer categories of the questionnaire covered a range of values, the midpoint of the range of frequency or amount was used. A subsample of 4030 participants were also interviewed about their alcohol consumption using the computerised dietary history program, called DISHES (Dietary Interview Software for Health Examination Studies) with documented validity (Mensink et al, 2001) .
Participants were divided into five alcohol consumption groups: 0, 40-10, 410-20, 420-30 and 430 g/day. Participant's education level, occupation, and household income were combined into a socioeconomic status index, which was classified as low, middle, and high. Information on tobacco use was categorised as never, current, and former smoker. Out of five possible answer categories based on the question 'How often do you engage in sports activity on a regular basis?', three categories were formed: 0, 40 to r2, 42 h sports activity per week. Coffee consumption was grouped in three frequency levels (never to seldom, (almost) daily, several times a day). Use of oral contraceptives, use of other hormones, and East/West Germany residence were included in the analyses as dichotomous variables. Body mass index (BMI) was calculated by dividing weight (in kilogram) by squared height (in metre). The HDL/total cholesterol ratio was calculated by the quotient of mean HDL and mean total cholesterol multiplied by 100.
Statistical analyses
The distribution of total glycerides was skewed and required logarithmical transformation prior to statistical computations. The appropriateness of controlling for potential confounders others than age, among them socioeconomic status, East/West Germany residence, BMI, tobacco use, sports activity, coffee consumption, and for women use of oral contraceptives and hormonotherapy, were considered for all statistical models and for each cardiovascular risk factor separately. Multiple-adjusted least-square means of blood lipids, haemostatic factors, and homocysteine as well as the standard errors of means (s.e.m.) within five alcohol consumption groups were calculated using analysis of variance with proc GLM in SAS. Tests for linear and polynomial trend were performed. In addition, differences in multiple-adjusted least-square means were tested using Student's t-test. Statistical significance was accepted if Pr.05. The analyses were repeated as stratified analyses for the three age groups 18-34, 35-54, and 55-79 y after multiple adjustment (age included). In a separated regression model, the effect of age groups was also tested by including the interaction variable age group Â alcohol consumption after multiple adjustment (age included) using the continuous variable of alcohol consumption.
In a separated analysis of variance, multiple-adjusted leastsquare means and s.e.m. of homocysteine within five alcohol consumption groups were calculated by alcohol intake from beer, wine, and spirits. The analyses on alcohol intake from one beverage type were adjusted for alcohol intake from the other beverages. All statistical analyses were performed for women and men separately, using SAS statistical software, version 8.2 (SAS Institute Inc.; Cary, NC, USA).
Results
Among women, mean alcohol consumption was 4.3 g/day (standard deviation: 8 g/day; range (max-min): 93 g/day) and median alcohol consumption was 1.4 g/day (interquartile range: 0.1-3.9 g/day). On average, female alcohol consumption from beer, wine, and spirits equalled 1.3, 2.8, and 0.5 g/day, respectively. Among men, mean alcohol consumption was 15.6 g/day (standard deviation: 20 g/day; range: 163 g/day) and the median was 7.6 g/day (interquartile range: 2.3-21.6 g/day). The beverage-specific mean alcohol consumption among men was highest for beer (11.4 g/day), followed by wine (3.4 g/day), and spirits (0.8 g/day). Further characteristics of the study population are summarised for women (Table 1 ) and men (Table 2) according to five groups of alcohol consumption.
Mean age was highest among persons who reported to drink 20-30 g alcohol/day. There was no relation between BMI and alcohol consumption groups among male individuals, whereas among women, the highest BMI was observed for nondrinkers. In higher alcohol consumption groups, the proportion of persons with high socioeconomic status were comparatively higher as well as of current smokers. The proportion of men from former East Germany to West Germany increased with each higher alcohol consumption group.
Differences in lipid, haemostatic, and homocysteine levels within alcohol consumption groups among women are shown in Table 3 , adjusted for multiple confounders. Total cholesterol showed no significant association with alcohol consumption among women, but the HDL cholesterol subfraction as well as the HDL/total cholesterol ratio did. Mean values of HDL cholesterol were þ 21.9% higher among women drinking more than 30 g alcohol/day as compared to nondrinkers (Po0.0001). Results on the HDL/total cholesterol ratio indicated a net gain of þ 14.5% for women consuming 10-20 g alcohol/day as compared to nondrinkers (Po0.0001), with no further significant increase in alcohol consumption groups 420 g alcohol/day. Despite the tendency of linear inverse association of fibrinogen and alcohol consumption among women, an alcohol consumption of more than 20 g/day was not associated with a significant further decrease compared to 10-20 g/day. A 6.6% decrease in fibrinogen level was observed in the 10-20 g/day alcohol consumption group as compared to nondrinkers (P ¼ 0.0007). The relation between alcohol consumption and homocysteine was (in tendency) U-shaped, with the minimum value in the alcohol consumption group of 10-20 g/day (À8.3%, P ¼ 0.0153, reference: nondrinking). Among men, at each level of alcohol consumption, total cholesterol was increased among drinkers as compared to nondrinkers (Table 4) . Mean values of HDL cholesterol were þ 20.8% higher among men drinking more than 30 g alcohol/day as compared to nondrinkers (Po0.0001). The respective increase in the HDL/total cholesterol ratio was þ 17.9% (Po0.0001). Fibrinogen had an inverse association with alcohol consumption among men. However, the lowest fibrinogen level was observed among those consuming 20-30 g alcohol/day as compared to those who did not drink (À6.9%, P ¼ 0.0006). A linear inverse association of homocysteine and alcohol consumption was apparent among men. A maximum decrease in homocysteine level by À11% was observed among men drinking more than 30 g alcohol/ day as compared to nondrinkers (P ¼ 0.0015).
Since alcoholic beverage type may have an influence on homocysteine level, separate analyses for beer, wine, and spirits were performed, adjusting for several confounders and the type of alcoholic beverage, simultaneously (Table 5) . Only alcohol from beer turned out to be associated with homocysteine level. The roughly U-shaped curve among women (P for quadratic trend: 0.0190) and the inverse relation among men (P for linear trend: 0.0008) corresponded to the relations shown for total alcohol consumption in Tables 3 and 4. Possible differences were also considered in the relation between alcohol consumption and cardiovascular risk factors among age groups. In multiple-adjusted regression models including an interaction term for age and alcohol consumption, the effect of alcohol consumption on total cholesterol, HDL cholesterol and HDL/total cholesterol was shown to be dependent on age. Such interaction with age was only apparent among men. Then, stratified analyses for the three age groups 18-34, 35-54 and 55-79 y were carried out for both men and women. Again, results from the stratified analyses showed some effect modification by age among men, but not women. Differences in total cholesterol and particularly HDL cholesterol according to alcohol consumption groups appeared to be more evident in the oldest age group compared to both younger age groups. Consequently, the increase in HDL/total cholesterol ratio with increasing alcohol consumption groups was not as high among the 18-34 y old and the 35-54 y old as among 55-79 y old men (Figure 1 ). The HDL/total cholesterol ratio in the oldest age group showed proportional differences of þ 8.5%, þ 19.7%, þ 30.3%, and þ 33.5% with respect to rising alcohol consumption groups (reference: nondrinker).
Discussion
The most favourable cardiovascular risk factor profile among women was observed among those drinking 10-20 g alcohol/ day. A higher alcohol consumption showed no further improvement and a less favourable homocysteine level. Favourable effects were already observed among women drinking up to 10 g alcohol/day as compared to nondrinkers. Among men, for several cardiovascular risk factors, including HDL cholesterol, HDL/total cholesterol ratio, fibrinogen, and homocysteine, the most favourable levels were observed for higher alcohol consumption groups than for nondrinkers. The beneficial effect of alcohol consumption on HDL/total cholesterol ratio seemed to be more pronounced among older men.
A consistent body of evidence suggests a positive relation between moderate alcohol consumption and HDL cholesterol (De Oliveira E Silva et al, 2000; Baer et al, 2002) . In a metaanalysis conducted by Rimm et al (1999) , 30 g alcohol/day was associated with an increase in HDL cholesterol concentrations of 0.10 mmol/l (3.99 mg/dl) compared to nondrinkers, which is lower than observed in our study. The estimated reduction in coronary heart disease was 16.8%. Results on the effect of alcohol consumption on total serum cholesterol are less consistent, although studies indicate a tendency of inverse relation for women and a positive Alcohol and risk factors of cardiovascular disease M Burger et al relation for men Nanchahal et al, 2000) . However, the proportion of cholesterol subfractions may be a more relevant indicator of cardiovascular disease risk. The positive association of alcohol consumption and HDL/total cholesterol ratio observed in this study corresponds to findings observed by others, although there are differences in the strength of the effect (Whitehead et al, 1996; Dimmitt et al, 1998; Nanchahal et al, 2000) . 
Alcohol and risk factors of cardiovascular disease M Burger et al
Although some studies showed an effect between alcohol consumption and total glyceride level Baer et al, 2002) , many did not (Rumpler et al, 1999; De Oliveira E Silva et al, 2000; Nanchahal et al, 2000) . The conflicting results may be due to uncontrolled confounding, such as pre-existing hypertriglyceridaemia, obesity, and length of fasting prior to venipuncture. In this study, the use of lipid lowering drugs was accounted for, which may have reduced bias due to hypertriglyceridaemia.
In the presented study, an inverse linear association was observed between alcohol consumption and fibrinogen, showing the largest difference between the nondrinkers and the alcohol consumption group 20-30 g alcohol/day. Men with an alcohol consumption above 30 g/day were further divided into consumption groups (430-40, 440-50, 450-60, 460-70, 470-80, 480 g alcohol/day), but no further reduction of fibrinogen was observed. The number of women with high alcohol consumption was small and no comparable analyses were performed for them. Intervention trials support a reduction of fibrinogen following an intake of 30-40 g alcohol per day as compared to nondrinkers (Pellegrini et al, 1996; Sierksma et al, 2002) . Some observa- Beverage type-adjusted analyses among men are also adjusted for age, socioeconomic status, East/West Germany residence, tobacco use, and coffee consumption if appropriate; beverage type-adjusted analyses among women are also adjusted for age, East/West Germany residence, tobacco use, coffee consumption, use of oral contraceptives, and hormonotherapy, if appropriate. s.e.m. standard error of the mean. A,B,C,D,E Significant difference to the indicated alcohol consumption group (Pp0.05) tested using Student's t-test. b Significant trend tested using the contrast option for linear and quadratic trend.
tional studies including high alcohol drinkers suggested a U-shaped curve for the association of alcohol consumption and fibrinogen, particularly among men, with the minimum of the curve ranging between 20 to 60 g alcohol/day (Krobot et al, 1992; Mennen et al, 1999; Mukamal et al, 2001) . In this study, no relation between alcohol consumption and antithrombin III was found, while results of other studies remained inconclusive (Kiechl et al, 1996; Mezzano et al, 2001) .
A U-shaped relation was observed in tendency between alcohol consumption and homocysteine among women and a linear inverse relation among men. Some observational studies showed contradictory results for women (Giles et al, 1999; de Bree et al, 2001) , however, the comparability of results might be restricted by the use of different consumption groups (Giles et al, 1999) . Several, although not all (Jacques et al, 2001 ) studies conducted among men or both genders indicated lower homocysteine levels with higher alcohol consumption (Ubbink et al, 1998; de Bree et al, 2001; Mayer et al, 2001) . Dixon et al (1992) observed a U-shaped curve with higher plasma homocysteine among predominantly women (male:female 1:5). Confounding factors such as genetic status and drinking pattern may contribute to the observed discrepancies between studies (Gudnason et al, 1998; Mukamal et al, 2001) . Some studies indicate that consumption of beer may have more favourable effects on homocysteine level than wine or spirits (de Bree et al, 2001; Jacques et al, 2001 ), a finding supported by our results. Whether the homocysteine-lowering effect of beer consumption can be attributed to its content of B-vitamins (particularly folate) (Ubbink et al, 1998; Mayer et al, 2001) or is independent of B-vitamins (de Bree et al, 2001; Dixon et al, 2002) , requires further research. Still, in a recent intervention trial vitamin B 6 in beer was suggested to prevent an alcohol-induced rise in serum homocysteine (van der Gaag et al, 2000) .
Although studies agree on a beneficial effect of moderate alcohol consumption on HDL cholesterol, the metabolic pathways are not entirely understood. Proposed mechanisms include an increased supply of lipids, lipoprotein particles, and apolipoproteins (apo) by the liver, and in the long term, an enhanced synthesis of nascent HDL particles (Amarasuriya et al, 1992; Rakic et al, 1998) . Another discussed mechanism focusses on an enhanced lipolysis of triglyceride-rich lipoprotein particles, for instance by an alteration in the activity of lipoprotein lipase, cholesterol ester transfer protein, hepatic lipase, and lecithin:cholesterol acyltransferase, although not confirmed by all studies (Hannuksela et al, 1992; Välimäki et al, 1993; Nishiwaki et al, 1994) . Moreover, alcohol may delay the cleaning of HDL particles from the blood stream, as demonstrated by intervention studies among primates as well as among men (Cluette-Brown et al, 1985; Gottrand et al, 1999) . Two turnover studies, however, failed to show a decreased catabolism of HDL particles in the human body (Malmendier and Delcroix, 1985; De Oliveira E Silva et al, 2000) .
Homocysteine is an intermediate product of the remethylation pathway and the trans-sulphuration pathway of methionine metabolism, which both may be influenced by alcohol consumption. An altered activity of methionine cycle enzymes like S-adenosylmethionine synthetase, betaine-homocysteine S-methyltransferase, methioninsynthase, and cystathionine b-synthase has been demonstrated in animal studies examining excessive alcohol consumption (Finkelstein et al, 1974; Barak et al, 1987; Trimble et al, 1993) . In relation to fibrinogen, the mechanisms may be specific and unrelated to C-reactive protein (Sierksma et al, 2001) . Some studies observed that the hepatic transcription of fibrinogen genes decreased with alcohol consumption (Wang et al, 1999) .
Self-reports on alcohol consumption are susceptible to measurement errors, particularly under-reporting. In this study, a food frequency questionnaire assessed both the frequency and amount of alcohol consumption from beer, wine, and spirits. In this way, more realistic consumption levels are obtained than without the differentiation of beverage type (Feunekes et al, 1999) . In a subsample of 4030 participants, the alcohol consumption reported in from the food frequency questionnaire was compared with that of a dietary history (DISHES 98), DISHES has been previously validated against 3-day weighted dietary records and a 24 h dietary recall (Mensink et al, 2001 ). Pearson's correlation coefficients for alcohol consumption between the food frequency questionnaire and the dietary history were 0.74 (Po0.0001) for women and 0.70 (Po0.0001) for men. The proportion of women and men classified into the same or adjacent quintile of intake were 98 and 87%, respectively. Measures of agreement revealed moderate agreement of alcohol consumption data (women: weighted kappa ¼ 0.46 (0.43-0.49); men: weighted kappa ¼ 0.52 (0.50-0.55); Po0.0001). It is impossible to correctly assess the absolute level of alcohol consumption (Feunekes et al, 1999) , however, the grouping of persons according to their alcohol consumption may have weakened the bias of assessment errors. Alcohol and risk factors of cardiovascular disease M Burger et al Potential confounding was carefully tested for each cardiovascular risk factor separately, and confounders were, if appropriate, adjusted. This included BMI, probably partly reflecting dietary habits. This also included East/West Germany residence, reflecting differences in alcohol consumption and lifestyle as well as social circumstances that go beyond the differences grasped by socioeconomic status. Still, residual confounding may exist for instance, from the intake of energy, fat, and those B-vitamins involved in homocysteine breakdown (Rumpler et al, 1999; Kesse et al, 2001) . Information on nutrient intake was not available from the food frequency questionnaire, but for the subgroup of persons participating in the DISHES interview, allowing for a sensitivity analysis with and without additional control for selected nutrient intake. In the sensitivity analysis, the relationship between alcohol consumption and cardiovascular risk factors remained consistent, except for the Ushaped relation with homocysteine (women) and the inverse relation with fibrinogen (men), which both became of borderline significance. Findings did not change after additional control for intake of energy, fat, folate, vitamin B 12 and -B 6 or use of vitamin and/or mineral supplements. Drinking patterns, particularly drinking frequency, have also been observed to affect cardiovascular disease risk (Mukamal et al, 2001) , however, further examination of drinking patterns would go beyond the scope of this study.
Long-term nondrinkers and persons who stopped because of health reasons, like coronary disease, may have a different risk profile (Shaper et al, 1988) . Therefore, participants who reported disease or drug use associated with cardiovascular risk factors were excluded from this study (about 30%). Nevertheless, repeated analyses including all participants resulted in a similar outcome.
Solely comparing the mean values of cardiovascular risk factors for alcohol consumption groups may be insufficient to conclude on a linear or curvilinear relation. Therefore, linear and polynomial trend tests were performed. The reported linear and curvilinear relations have been confirmed by linear and polynomial multiple-adjusted regression analyses with alcohol consumption as a continuous variable (not shown).
Studies documenting a U-shaped relation between alcohol consumption and ischaemic heart disease have partially been supported by our results, particularly by those found for women (Stampfer et al, 1988; Rehm et al, 1997; Corrao et al, 2000) . In the same way, the most preferable risk factor levels of HDL/total cholesterol ratio, fibrinogen, and homocysteine were observed at lower drinking amounts for women than men. Differences in body composition and decreased first pass metabolism of ethanol may contribute to the higher alcohol sensitivity of women (Mumenthaler et al, 1999; NIAAA, 1999) .
Several studies suggest a lower alcohol-associated cardiovascular disease risk among older than younger persons (Stampfer et al, 1988; Shaper et al, 1994) . This corresponds to the stronger increase in HDL/total cholesterol ratio among 55-79 y-old men compared to younger men. The biological basis for differences in the effect of alcohol consumption on cardiovascular risk factors among age groups may not be strong, but there are some aspects that are worth considering. Alcohol consumption is subject to age (KlipsteinGrobusch et al, 1999) . For instance, young adults typically show a drinking pattern referred to as binge drinking, whereas older persons may drink more regularly than younger persons. Older persons may also differ in other conditions like nutrient intake. Among women, the association of alcohol consumption and cardiovascular risk factors was similar among age groups. Information on pre-and postmenopausal status among women was not directly available. However, analyses were repeated, comparing women aged below 50 y with women aged above 50 y. The age above 50 years is more likely to reflect postmenopausal status, a phase of life correlated with an increased risk of alcohol-associated cardiovascular events (Stampfer et al, 1988; Fuchs et al, 1995; Thun et al, 1997) . However, results remained the same.
Results of this study indicate that moderate alcohol consumption has a favourable effect on several cardiovascular risk factors and thereby, probably on the prevalence of cardiovascular disease. The mechanisms by which alcohol exerts its effects, however, are still a matter of debate. Among women, favourable differences in cardiovascular risk factors seemed to be restricted to an alcohol consumption below 20 g/day. To our knowledge, we showed for the first time that the beneficial effects of moderate alcohol consumption among men may possibly be more pronounced among older persons. Overall, the effect of alcohol consumption should be considered in context with drinking patterns and the presence of additional cardiovascular risk factors, but also in relation to the individual's general health (Puddey and Croft, 1999) . Finally, any potential benefits of alcohol consumption have to be weighted against the potential risks, such as cancer, accidents, and social problems (Thun et al, 1997; Maier et al, 1999; NIAAA, 2000) .
